Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GE, NetBio to Validate Fully Integrated Rapid DNA system

Published: Friday, March 21, 2014
Last Updated: Thursday, March 27, 2014
Bookmark and Share
Verification by forensic laboratories is a key step toward responsible adoption for crime laboratory and in-the-field law enforcement use.

GE Healthcare Life Sciences and NetBio announce that an extensive developmental validation of DNAscan™ Rapid DNA Analysis™ System has commenced. The studies will evaluate the overall system from swab-in to profile-out, including the instrument, NetBio BioChipSet™ Cassette, STR chemistry, and data interpretation by the on-board Expert System Software. The software enables fully automated data analysis which will be critical to Rapid DNA Analysis realizing its full potential outside the laboratory. This approach to validation will pave the way for future uptake of Rapid DNA by crime laboratories and police stations globally.

Mike Benevento, General Manager, Human Identification, GE Healthcare Life Sciences, said: "Rapid DNA analysis will significantly increase the speed with which DNA supports the investigation of crimes and is predicted to substantially reduce violent and property crime over time. Together with NetBio, we are committed to the responsible adoption of DNAscan Rapid DNA Analysis System which is essential to successfully realizing this potential, not just in the United States, but globally. We are working closely with the FBI, SWGDAM (Scientific Working Group for DNA Analysis Methods), and others in the forensic and law enforcement communities to take a considered, step-wise approach to the introduction of the DNAscan System."

Developmental validation of the system comprises an extensive series of tests to verify that results generated (STR profiles) are reliable and reproducible. A working group which includes five accredited forensic laboratories is independently generating and analyzing data from the DNAscan System. This verification process, which includes meeting an extensive set of FBI Quality Assurance Standards, is expected by the forensic science community for any new scientific technology being introduced into the criminal justice system. Following analysis, the results will be used to seek National DNA Index System (NDIS) approval which will allow forensic laboratories to submit the STR profiles generated by the DNAscan System to the U.S. national DNA database (CODIS). NDIS approval is also a critical step toward the ultimate goal of obtaining approval for use in the police station.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare Life Sciences to Open Biopharmaceutical Technology and Training Laboratory in Turkey
Supports Turkey’s ambitions to expand domestic biopharmaceutical industry. Laboratory will be a key component of GE’s new Innovation Center in Istanbul.
Friday, November 14, 2014
GE Healthcare Life Sciences Named as Finalist for Four Bioprocess Industry Awards
Awards celebrate and recognize the outstanding people, organizations and technologies.
Saturday, October 04, 2014
GE Healthcare Life Sciences to Create New US Headquarters
When fully operational, the new facility will house more than 500 highly skilled employees and bring more than 220 new jobs to Massachusetts.
Wednesday, August 20, 2014
GE Healthcare Appoints Emmanuel Ligner as General Manager
Emmanuel will oversee all worldwide commercial activities of Company's rapidly growing BioProcess business.
Friday, April 11, 2014
Spectacular Images Showing Research into Cancer, Neurodegenerative Disease and Fertility
Vanessa Auld from Canada, Martin Barr from Ireland and Graham Wright from Singapore announced as the winners of the GE Healthcare 2013 Cell Imaging Competition.
Wednesday, March 12, 2014
GE Healthcare to Build KUBio Factory for JHL Biotech in China
New factory to give JHL Biotech commercial biopharmaceutical manufacturing capabilities in Asia.
Thursday, September 26, 2013
GE Healthcare Life Sciences and Osaka University Team Up
Top four graduate students to be hosted at GE Healthcare Life Science’s Uppsala site.
Wednesday, August 21, 2013
GE Healthcare Life Sciences Completes Acquisition of Xcellerex, Inc.
Acquisition expands GE Healthcare’s offering of technologies and services for the manufacture of recombinant proteins, antibodies and vaccines.
Tuesday, May 15, 2012
Scientific News
Health Risks of Saturated Fats Aggravated by Immune Response
Research shows that the presence of saturated fats resulted in monocytes migrating into the tissues of vital organs.
Changing the Biological Data Visualisation World
Scientists at TGAC, alongside European partners, have created a cutting-edge, open source community for the life sciences.
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!